Risk Factors of Progression in Low-tumor Burden Follicular Lymphoma Initially Managed by Watch and Wait in the Era of PET and Rituximab

Risk Factors of Progression in Low-tumor Burden Follicular Lymphoma Initially Managed by Watch and Wait in the Era of PET and Rituximab

Patients (pts) with asymptomatic low-burden follicular lymphoma (FL) are usually observed at diagnosis. Time to lymphoma treatment (TLT) initiation can however be very heterogeneous and risk factors of progression are poorly studied. Our study evaluated 201 pts with grade 1–3a low-tumor burden FL di...

Full description

Bibliographic Details
Main Authors: Cyrielle Rodier, Lukshe Kanagaratnam, David Morland, Adélie Herbin, Amandine Durand, Adrien Chauchet, Sylvain Choquet, Philippe Colin, René Olivier Casasnovas, Eric Deconinck, François Godard, Alain Delmer, Cédric Rossi, Eric Durot
Format: Article
Language:English
Published: Wiley 2023-05-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/HS9.0000000000000861

Internet

http://journals.lww.com/10.1097/HS9.0000000000000861

Similar Items